- Description
- Table of Contents
- Request Sample
The Global Cell Therapies & Oncolytic Virus market is growing at a CAGR of 17.32% from 2018 to 2026. Oncolytic virus is considered as a genetically built or naturally occurring virus that will kill the cancer cells without hurting the ordinary human tissues. Oncolytic Virus therapy is known to be another therapeutic methodology utilized for treating cancer and is showing promising outcomes globally. With the innovations made in oncology and the virology, there are possible routes towards the engineering of viruses showing increased tumor selectivity and increased oncolytic activity. Factors such as rise in technological advancements and increase in usage of combination therapies are driving the market growth. Though, occurrence of immune reaction to the virus-based treatments caused by repeated administration of therapeutics to treat cancer and Staggering expense related to oncolytic virus therapy are projected to inhibit the growth of the market. Moreover, stimulation of the intrinsic vascular cell may provide ample opportunities for the market growth. By application, melanoma segment acquired significant growth in the market because most of the cancer therapies are developed for melanoma cancers. Increasing prostate cancer cases are also leading to the strong growth rate in prostate cancer therapies in recent years which is driving the market growth. The key vendors mentioned are PsiOxus Therapeutics, Cold Genesys, TILT Biotherapeutics, SillaJen Biotherapeutics, Genelux Corporation, Vyriad, Lokon Pharma, TILT Biotherapeutics and Sorrento Therapeutics. Types Covered: • Adenoviruses-Based Oncolytic viruses • HSV-Based Oncolytic Viruses • Newcastle Disease Virus-Based Oncolytic Viruses • Vaccinia Virus-Based Oncolytic Viruses • Vesicular Stomatitis Virus-Based Oncolytic Viruses Applications Covered: • Breast Cancer • Melanoma • Ovarian Cancer • Prostate cancer Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cell Therapies & Oncolytic Virus Market, By Type
5.1 Introduction
5.2 Adenoviruses-Based Oncolytic viruses
5.3 HSV-Based Oncolytic Viruses
5.4 Newcastle Disease Virus-Based Oncolytic Viruses
5.5 Vaccinia Virus-Based Oncolytic Viruses
5.6 Vesicular Stomatitis Virus-Based Oncolytic Viruses
6 Global Cell Therapies & Oncolytic Virus Market, By Application
6.1 Introduction
6.2 Breast Cancer
6.3 Melanoma
6.4 Ovarian Cancer
6.5 Prostate cancer
7 Global Cell Therapies & Oncolytic Virus Market, By Geography
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 South America
7.6 Middle East & Africa
8 Strategic Benchmarking
9 Vendors Landscape
9.1 PsiOxus Therapeutics
9.2 Cold Genesys
9.3 TILT Biotherapeutics
9.4 SillaJen Biotherapeutics
9.5 Genelux Corporation
9.6 Vyriad
9.7 Lokon Pharma
9.8 TILT Biotherapeutics
9.9 Sorrento Therapeutics
List of Data Tables
Table 1 Global Cell Therapies & Oncolytic Virus Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Cell Therapies & Oncolytic Virus Market Outlook, By Adenoviruses-Based Oncolytic viruses (2016-2026) ($MN)
Table 4 Global Cell Therapies & Oncolytic Virus Market Outlook, By HSV-Based Oncolytic Viruses (2016-2026) ($MN)
Table 5 Global Cell Therapies & Oncolytic Virus Market Outlook, By Newcastle Disease Virus-Based Oncolytic Viruses (2016-2026) ($MN)
Table 6 Global Cell Therapies & Oncolytic Virus Market Outlook, By Vaccinia Virus-Based Oncolytic Viruses (2016-2026) ($MN)
Table 7 Global Cell Therapies & Oncolytic Virus Market Outlook, By Vesicular Stomatitis Virus-Based Oncolytic Viruses (2016-2026) ($MN)
Table 8 Global Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)
Table 9 Global Cell Therapies & Oncolytic Virus Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 10 Global Cell Therapies & Oncolytic Virus Market Outlook, By Melanoma (2016-2026) ($MN)
Table 11 Global Cell Therapies & Oncolytic Virus Market Outlook, By Ovarian Cancer (2016-2026) ($MN)
Table 12 Global Cell Therapies & Oncolytic Virus Market Outlook, By Prostate cancer (2016-2026) ($MN)
Table 13 North America Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 14 North America Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)
Table 15 Europe Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 16 Europe Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)
Table 17 Asia Pacific Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 18 Asia Pacific Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)
Table 19 South America Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 20 South America Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)
Table 21 Middle East & Africa Cell Therapies & Oncolytic Virus Market Outlook, By Type (2016-2026) ($MN)
Table 22 Middle East & Africa Cell Therapies & Oncolytic Virus Market Outlook, By Application (2016-2026) ($MN)